FDA Bioequivalence Study On Metoprolol Shows Emerging Generic Investigation Strategy
This article was originally published in The Pink Sheet Daily
Executive Summary
Outside research project launches after FDA does not find a safety signal in its internal investigation into generic versions of AstraZeneca’s Toprol XL.